Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Cite
CITATION STYLE
APA
Berger, M. J., Ettinger, D. S., Aston, J., Barbour, S., Bergsbaken, J., Bierman, P. J., … Hughes, M. (2017). NCCN Guidelines Insights: Antiemesis, Version 2.2017. Journal of the National Comprehensive Cancer Network, 15(7), 883–893. https://doi.org/10.6004/jnccn.2017.0117
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free